Despite a decline in total revenue, Edap TMS SA (EDAP) reports significant growth in its HIFU segment and outlines optimistic projections for 2026.

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of U.S ...

Webcast scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023-- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies ...

Editor’s Note: This piece was submitted by a contributing writer and does not represent the views of CURE Media Group. If I could have blown a whistle and called a foul in the doctor's office, I might ...

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

EDAP is still attractively priced when considering multiple growth drivers. The company is building momentum around its HIFU segment, and my numbers call for 20% YoY growth in turnover. Here I explain ...

Sponsored FOY Math Professor Back in Class After Beating Prostate Cancer Desai Sethi Urology Institute Offers HIFU Procedure Minimizing Side Effects When Will Neris was diagnosed with prostate cancer ...